Abstract:Background Tumour‐induced skeletal muscle wasting in the context of cancer cachexia is a condition with profound implications for patient survival. The loss of muscle mass is a significant clinical obstacle and is linked to reduced tolerance to chemotherapy and increased frailty. Understanding the molecular mechanisms driving muscle atrophy is crucial for the design of new therapeutics. Methods Lewis lung carcinoma tumours were utilized to induce cachexia and muscle atrophy in mice. Single‐nucleus libraries of the tibialis anterior (TA) muscle from tumour‐bearing mice and their non‐tumour‐bearing controls were constructed using 10X Genomics applications following the manufacturer's guidelines. RNA sequencing results were analysed with Cell Ranger software and the Seurat R package. Oxygen consumption of mitochondria isolated from TA muscle was measured using an Oroboros O2k‐FluoRespirometer. Mouse primary myotubes were treated with a recombinant ectodysplasin A2 (EDA‐A2) protein to activate EDA‐A2 receptor (EDA2R) signalling and study changes in gene expression and oxygen consumption. Results Tumour‐bearing mice were sacrificed while exhibiting moderate cachexia. Average TA muscle weight was reduced by 11% (P = 0.0207) in these mice. A total of 12 335 nuclei, comprising 6422 nuclei from the control group and 5892 nuclei from atrophying muscles, were studied. The analysis of single‐nucleus transcriptomes identified distinct myonuclear gene signatures and a shift towards type IIb myonuclei. Muscle atrophy‐related genes, including Atrogin1, MuRF1 and Eda2r, were upregulated in these myonuclei, emphasizing their crucial roles in muscle wasting. Gene set enrichment analysis demonstrated that EDA2R activation and tumour inoculation led to similar expression patterns in muscle cells, including the stimulation of nuclear factor‐kappa B, Janus kinase–signal transducer and activator of transcription and transforming growth factor‐beta pathways and the suppression of myogenesis and oxidative phosphorylation. Muscle oxidative metabolism was suppressed by both tumours and EDA2R activation. Conclusions This study identified tumour‐induced transcriptional changes in muscle tissue at single‐nucleus resolution and highlighted the negative impact of tumours on oxidative metabolism. These findings contribute to a deeper understanding of the molecular mechanisms underlying muscle wasting.

Tumor-Derived Ligands Trigger Tumor Growth and Host Wasting Via Differential MEK Activation.

A tumor-secreted protein utilizes glucagon release to cause host wasting

Coordination of tumor growth and host wasting by tumor-derived Upd3

Tumor Cytokine-Induced Hepatic Gluconeogenesis Contributes to Cancer Cachexia: Insights from Full Body Single Nuclei Sequencing

Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90

Drosophila Larval Models of Invasive Tumorigenesis for In Vivo Studies on Tumour/Peripheral Host Tissue Interactions during Cancer Cachexia

Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia

Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy.

MEF2D Facilitates Liver Metastasis of Gastric Cancer Cells Through Directly Inducing H1X under IL-13 Stimulation

ERK and c-Myc signaling in host-derived tumor endothelial cells is essential for solid tumor growth

Convergent insulin and TGF-β signalling drives cancer cachexia by promoting aberrant fat body ECM accumulation in a Drosophila tumour model

A Subset of Metastatic Pancreatic Ductal Adenocarcinomas Depends Quantitatively on Oncogenic Kras/Mek/Erk-Induced Hyperactive Mtor Signalling

A Tumor-Specific Molecular Network Promotes Tumor Growth in Drosophila by Enforcing a Jun N-Terminal Kinase–Yorkie Feedforward Loop

The TWEAK/Fn14 signaling promotes skeletal muscle wasting during cancer cachexia

Tumor Microenvironment Regulation by the Endoplasmic Reticulum Stress Transmission Mediator Golgi Protein 73 in Mice

Paraneoplastic renal dysfunction in fly cancer models driven by inflammatory activation of stem cells

Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation

ZIP4 Promotes Muscle Wasting and Cachexia in Mice with Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles from Cancer Cells.

Mechanistic characterization of a Drosophila model of paraneoplastic nephrotic syndrome

Tumour‐induced alterations in single‐nucleus transcriptome of atrophying muscles indicate enhanced protein degradation and reduced oxidative metabolism

C-C chemokine ligand 2 signaling promotes skeletal muscle wasting in non-tumor and breast tumor mouse models